247 related articles for article (PubMed ID: 19331181)
1. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
Sponring A; Filipiak W; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Anticancer Res; 2009 Jan; 29(1):419-26. PubMed ID: 19331181
[TBL] [Abstract][Full Text] [Related]
2. TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro.
Filipiak W; Sponring A; Filipiak A; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):182-95. PubMed ID: 20056637
[TBL] [Abstract][Full Text] [Related]
3. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
4. Breath analysis in non small cell lung cancer patients after surgical tumour resection.
Poli D; Goldoni M; Caglieri A; Ceresa G; Acampa O; Carbognani P; Rusca M; Corradi M
Acta Biomed; 2008; 79 Suppl 1():64-72. PubMed ID: 18924311
[TBL] [Abstract][Full Text] [Related]
5. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H
J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381
[TBL] [Abstract][Full Text] [Related]
6. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
7. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
8. Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.
Filipiak W; Sponring A; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Cancer Cell Int; 2008 Nov; 8():17. PubMed ID: 19025629
[TBL] [Abstract][Full Text] [Related]
9. Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells.
Sponring A; Filipiak W; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Cancer Biomark; 2010; 7(3):153-61. PubMed ID: 21263191
[TBL] [Abstract][Full Text] [Related]
10. Determination of volatile organic compounds in human breath for Helicobacter pylori detection by SPME-GC/MS.
Ulanowska A; Kowalkowski T; Hrynkiewicz K; Jackowski M; Buszewski B
Biomed Chromatogr; 2011 Mar; 25(3):391-7. PubMed ID: 21321973
[TBL] [Abstract][Full Text] [Related]
11. Determination of volatile biomarkers for apoptosis and necrosis by solid-phase microextraction-gas chromatography/mass spectrometry: a pharmacometabolomic approach to cisplatin's cytotoxicity to human lung cancer cell lines.
Pyo JS; Ju HK; Park JH; Kwon SW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):170-4. PubMed ID: 19027370
[TBL] [Abstract][Full Text] [Related]
12. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics.
Rudnicka J; Kowalkowski T; Ligor T; Buszewski B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3360-6. PubMed ID: 21982505
[TBL] [Abstract][Full Text] [Related]
13. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
14. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS.
Poli D; Goldoni M; Corradi M; Acampa O; Carbognani P; Internullo E; Casalini A; Mutti A
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2643-51. PubMed ID: 20149763
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy control by breath profile with application of SPME-GC/MS method.
Ulanowska A; Trawińska E; Sawrycki P; Buszewski B
J Sep Sci; 2012 Nov; 35(21):2908-13. PubMed ID: 23001965
[TBL] [Abstract][Full Text] [Related]
16. Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography-mass spectrometry.
Preti G; Thaler E; Hanson CW; Troy M; Eades J; Gelperin A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):2011-8. PubMed ID: 19553163
[TBL] [Abstract][Full Text] [Related]
17. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
[TBL] [Abstract][Full Text] [Related]
18. Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry.
Smith D; Wang T; Sulé-Suso J; Spanel P; El Haj A
Rapid Commun Mass Spectrom; 2003; 17(8):845-50. PubMed ID: 12672140
[TBL] [Abstract][Full Text] [Related]
19. Quantification of acetaldehyde and carbon dioxide in the headspace of malignant and non-malignant lung cells in vitro by SIFT-MS.
Sulé-Suso J; Pysanenko A; Spanel P; Smith D
Analyst; 2009 Dec; 134(12):2419-25. PubMed ID: 19918611
[TBL] [Abstract][Full Text] [Related]
20. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
